Business article - February 24, 2020
Q&A: Richard Godfrey, CEO of BerGenBio
It is an exciting year for BerGenBio and its AXL inhibitor. Upcoming trial data will define their way forward towards a new approach to fighting cancer and improving the efficacy of cancer treatments. The Norwegian clinical stage biopharmaceutical company BerGenBio, founded in 2007, is based on identification and understanding of the protein AXL kinase. This […]
Business article - December 10, 2019
”A combination of great science, great projects and great people”
BioArctic’s lead compound has the potential to become the first disease-modifying treatment for Alzheimer’s, and so far the company’s journey has involved FDA approvals, a successful deal with AbbVie, collaborations with universities – and not least, the hiring of a very dedicated CEO. For years the treatments for central nervous system diseases such as Alzheimer’s […]
Business article - December 1, 2019
Business Q&A: Karl Bergman, CEO of Elypta
The days of Swedish liquid biopsy startup Elypta are hectic – the company has won prestigious awards and grants, and they will soon initiate the largest study in the world within kidney cancer diagnostics. The company’s method involves measuring a unique panel of metabolites whose composition has been found to be altered in the blood […]
Business article - August 26, 2019
Mini-interview: Monica Wallter, CEO of LIDDS
The last few months have been very eventful for LIDDS; the last patient has been enrolled in their localized treatment of prostate cancer study and they are evaluating a possible listing on Nasdaq Stockholm’s Main Market. The CEO of LIDDS, Monica Wallter, gives us an update. What’s next for LIDDS and what results can we […]
Business article - June 27, 2019
Coala Life raises SEK 11 million
The Swedish company has won the backing of the investment company Blue, which has placed an additional SEK 10 million investment (together with investments from the executives at the company) in the company following an earlier round of SEK93 million announced in April this year. The capital intake from Blue will enable Coala Life to […]
Business article - June 24, 2019
13 Scandinavian start-ups granted EIT Health Headstart funding
The start-ups were selected from around 50 applicants and the funding will allow the start-ups to take steps towards market launch and commercialization. The 13 start-ups represent solutions in medtech, digital health and diagnostics. They span areas from cancer diagnostics and multiparametric tests, surgical equipment, medical technologies related to Alzheimers, cancer treatment software, dental implants, […]
